AI assistant
Medtronic plc — Director's Dealing 2015
Aug 5, 2015
29841_dirs_2015-08-05_a62b0ae1-b693-49c0-ac96-33e110546a5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2015-08-03
Reporting Person: HAKAMI HOOMAN (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-03 | Ordinary Shares | A | 10257 | — | Acquired | 36802 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-03 | Employee Stock Option (right to buy) | $78 | A | 41026 | Acquired | 2025-08-03 | Ordinary Shares (41026) | Direct |
| 2015-08-03 | Employee Stock Option (right to buy) | $78 | A | 1283 | Acquired | 2025-08-03 | Ordinary Shares (1283) | Direct |
Footnotes
F1: This balance increased by 558 shares due to exempt transactions such as dividend reinvestment.
F2: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2018 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee.
F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.